Darbepoetin Alfa Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mcg, 20 mcg, 30mcg, 40mcg, 50 mcg and 100 mcg
Reference Brands: Aranesp (US & EU), Cresp (India)
Category: Nephrology
Darbepoetin Alfa Injection is a long-acting ESA used to treat anemia in chronic kidney disease and cancer patients. Marketed as Aranesp® in the US and EU, it is ideal for nephrology and oncology care, and widely used in Pharma B2B supply chains.
Product Description:
Darbepoetin Alfa Injection is a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease (CKD) and chemotherapy. Designed to reduce the frequency of dosing compared to epoetin alfa, it supports effective red blood cell production in patients with renal or cancer-related anemia. It is marketed under the brand names Aranesp® in both the US and EU. Ideal for hospital use and nephrology practices, Darbepoetin Alfa is a vital product for pharmaceutical distributors and global buyers. Partner with us for high-quality Darbepoetin Alfa Injection for your B2B pharma supply and international procurement needs.
Darbepoetin Alfa Injection — third party manufacturing & bulk supply
Darbepoetin Alfa Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Darbepoetin Alfa Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Darbepoetin Alfa Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Darbepoetin Alfa Injection is used to treat anemia caused by chronic kidney disease and anemia in patients receiving chemotherapy. It helps stimulate the production of red blood cells in the body.
Darbepoetin Alfa is a recombinant erythropoiesis-stimulating agent (ESA) produced using biotechnology that stimulates the bone marrow to produce more red blood cells.
Common trade names include Aranesp, Cresp, Nesp, and Dargen.
The original brand Aranesp was developed and marketed by the pharmaceutical company Amgen, while other pharmaceutical companies manufacture biosimilar darbepoetin alfa products.
The generic name is Darbepoetin Alfa.
Common brand names include Aranesp, Cresp, Nesp, and Dargen.
Darbepoetin Alfa Injection is manufactured in several countries including the United States, India, and other regions by different pharmaceutical manufacturers.
Related Products
Atrasentan Hydrochloride
Strength:
0.75 mg, 1.25 mg, 10 mg
Form: Tablets
Reference Brands: Xinlay (USA/EU), Vanrafia (USA/LATAM)
View Details
Tiopronin
Strength:
100 mg, 200 mg , 300 mg
Form: Tablets, Capsules
Reference Brands: Thiola (USA), Mercaptamine (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
